Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Lumbar spine BMD was not available for one patient due to L1 to L4 vertebral fractures.Baseline characteristics of patients included in the studyBaseline characteristics of the sampleSex, n (%;95% CI)♂ 60 (71.4; 61.1, 80.3)♀ 24 (28.6; 19.7, 38.9)Age in years, mean (± SD)59 (± 13)Body mass index in kg/m2, mean (± SD)28.9 (± 4.7)Presence of syndesmophytes, n (%;95% CI)40 (47.6; 37.1, 58.3)Presence of osteophytes, n (%;95% CI)18 (21.4; 13.6, 31.2)Treatment with NSAIDs, n (%;95% CI)43 (51.2; 40.6, 61.8)Treatment with biologics, n (%;95% CI)41 (48.8; 38.3, 59.5)Disease duration in range of years, n (%;95% CI) > 10 years55 (65.5; 54.9, 75) 5 to 10 years17 (20.2; 12.7, 29.8) < 5 years12 (14.3; 7.9, 23) BASDAI, mean (± SD) (n = 52)3.7 (± 2.2) BASFI, mean (± SD) (n = 52)4.3 (± 2.3) ASDAS, mean (± SD) (n = 38)2.7 (± 0.9) CRP mg/L, median (IQR)5 (53) ESR mm/h, median (IQR)9 (57) 25-OH-D ng/dL, median (IQR) (n = 78)24 (66) Blood calcium mg/dL, mean (± SD) (n = 76)9.4 (± 0.4) 24-h urinary calcium, median (IQR) (n = 33)143 (421) PTH pg/mL, median (IQR) (n = 40)47 (114) ALP UI/L, median (IQR) (n = 70)71.5 (180) β-CTX pg/mL, median (IQR) (n = 45)374 (901)Lumbar spine T-score Osteoporosis, n (%;95% CI)a 6 (7.2; 3, 14.4) Osteopenia, n (%;95% CI)a 10 (12;6.3, 20.4)Hip T-score Osteoporosis, n (%;95% CI)a 12 (14.8; 8.3, 23.9) Osteopenia, n (%;95% CI)a 18 (22.2; 14.2, 32.2)Lumbar spine Z-score Low bone mass, n (%;95% CI)a 2 (2.4;0.4, 7.7)Hip Z-score Low bone mass, n (%;95% CI)a 0TBS range (n = 81) Low, n (%;95% CI)14 (17.3; 10.2, 26.7) Intermediate, n (%;95% CI)18 (22.2; 14.2, 32.2) Presence of vertebral fracture, n (%;95% CI)10 (11.9; 6.2, 20.2) n number of patients, CI confidence interval, SD standard deviation, IQR interquartile range, NSAIDs nonsteroidal anti-inflammatory drugs, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Disease Functional Index, ASDAS Ankylosing Spondylitis Disease Activity Score, CRP C-reactive protein, ESR erythrocyte sedimentation rate, 25-OH-D 25-hydroxy vitamin D, PTH parathyroid hormone, ALP alkaline phosphatase, β-CTX β-CrossLaps (β-CTX), T-score: standard deviation of the mean for the young adult population of the same sex and geographical area, Z-score: standard deviation of the mean for the population of the same age range, TBS: trabecular bone score. aPercentages were calculated based on the total study sample with available data.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis reported · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A cross-sectional study was conducted.
Source: Abstract.
Patients were divided into three groups according to this criterion.
Source: Methods.
We classified TBS using the ranges described in the meta-analysis published by McCloskey et al.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Relationship between trabecular bone score, bone mineral density and vertebral fractures in patients with axial spondyloarthritis
Cross-sectional study · BMC Musculoskeletal Disorders · 2023
Original publication title
Relationship between trabecular bone score, bone mineral density and vertebral fractures in patients with axial spondyloarthritis
© The Author(s) 2023
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
In patients with axial spondyloarthritis, vertebral fracture risk is elevated and not always correlated with bone mineral density (BMD). Trabecular bone score (TBS) may offer some advantages in the assessment of vertebral fracture risk in these patients. The primary objective of this study was to compare TBS and BMD between axial spondyloarthritis patients depending on their vertebral fracture status. Secondary objectives were to estimate the prevalence of morphometric vertebral fractures, and to explore factors associated with fracture, as well as the interference of syndesmophytes on BMD and TBS.
Source: BackgroundAbstract: What methods does the paper describe?
A cross-sectional study was conducted. Data were collected on demographic and clinical characteristics, lab results, imaging findings and treatment. Statistical analysis was performed using SPSS v.13 statistical software.
Source: MethodsAbstract: Results
Eighty-four patients (60 men and 24 women; mean age of 59 years) were included. Nearly half (47.6%) of them had lumbar syndesmophytes. The rate of morphometric fracture was 11.9%. TBS showed a higher area under the curve (0.89) than total hip, femoral neck and lumbar BMD (0.80, 0.78, and 0.70 respectively) for classifying patients regarding their fracture status. Nonetheless, the differences did not reach statistical significance.
Syndesmophytes affected lumbar spine BMD (p < 0.001), but not hip BMD or TBS. Fractures were associated with TBS, total hip BMD, erythrocyte sedimentation rate and C-reactive protein levels.
Source: Results Source: ResultsAbstract: Conclusions
We identified decreased TBS and total hip BMD, as well as increased erythrocyte sedimentation rate and C-reactive protein levels as factors associated with morphometric vertebral fractures. Unlike lumbar spine BMD, TBS is not affected by the presence of syndesmophytes.
Source: ConclusionsAuthors’ abstract
Background
In patients with axial spondyloarthritis, vertebral fracture risk is elevated and not always correlated with bone mineral density (BMD). Trabecular bone score (TBS) may offer some advantages in the assessment of vertebral fracture risk in these patients. The primary objective of this study was to compare TBS and BMD between axial spondyloarthritis patients depending on their vertebral fracture status. Secondary objectives were to estimate the prevalence of morphometric vertebral fractures, and to explore factors associated with fracture, as well as the interference of syndesmophytes on BMD and TBS.
Methods
A cross-sectional study was conducted. Data were collected on demographic and clinical characteristics, lab results, imaging findings and treatment. Statistical analysis was performed using SPSS v.13 statistical software.
Results
Eighty-four patients (60 men and 24 women; mean age of 59 years) were included. Nearly half (47.6%) of them had lumbar syndesmophytes. The rate of morphometric fracture was 11.9%. TBS showed a higher area under the curve (0.89) than total hip, femoral neck and lumbar BMD (0.80, 0.78, and 0.70 respectively) for classifying patients regarding their fracture status. Nonetheless, the differences did not reach statistical significance.
Syndesmophytes affected lumbar spine BMD (p < 0.001), but not hip BMD or TBS. Fractures were associated with TBS, total hip BMD, erythrocyte sedimentation rate and C-reactive protein levels.
Conclusions
We identified decreased TBS and total hip BMD, as well as increased erythrocyte sedimentation rate and C-reactive protein levels as factors associated with morphometric vertebral fractures. Unlike lumbar spine BMD, TBS is not affected by the presence of syndesmophytes.
Publication and source details
Original title: Relationship between trabecular bone score, bone mineral density and vertebral fractures in patients with axial spondyloarthritis
Elia Valls-Pascual; Ana Victoria Orenes-Vera; Ana Sendra-García; Àngels Martínez-Ferrer; Lydia Montolío-Chiva; Ignacio Vázquez-Gómez; Eduardo Flores-Fernández; Desamparados Ybáñez-García; María Vega-Martínez; Luis García-Ferrer; Magdalena Graells-Ferrer; Juan José Alegre-Sancho
BMC Musculoskeletal Disorders · 2023
© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T19:37:07.631188+00:00
DOI: 10.1186/s12891-023-06431-9 · PMC10122358